K0U Stock Overview
Operates medical laboratories in the People’s Republic of China. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Adicon Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.73 |
52 Week High | HK$1.53 |
52 Week Low | HK$0.73 |
Beta | 0 |
11 Month Change | -3.92% |
3 Month Change | -28.64% |
1 Year Change | -38.75% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.23% |
Recent News & Updates
Recent updates
Shareholder Returns
K0U | DE Healthcare | DE Market | |
---|---|---|---|
7D | -3.3% | 1.1% | 0.2% |
1Y | -38.8% | 16.5% | 8.5% |
Return vs Industry: K0U underperformed the German Healthcare industry which returned 16.5% over the past year.
Return vs Market: K0U underperformed the German Market which returned 8.5% over the past year.
Price Volatility
K0U volatility | |
---|---|
K0U Average Weekly Movement | 7.9% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: K0U's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: K0U's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 5,456 | Song Gao | www.adicon.com.cn |
Adicon Holdings Limited operates medical laboratories in the People’s Republic of China. The company offers medical testing, clinical trials, scientific research services, health management, and pathological consultation services. It is also involved in the trading of medical testing equipment.
Adicon Holdings Limited Fundamentals Summary
K0U fundamental statistics | |
---|---|
Market cap | €558.67m |
Earnings (TTM) | €29.78m |
Revenue (TTM) | €413.44m |
18.8x
P/E Ratio1.4x
P/S RatioIs K0U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
K0U income statement (TTM) | |
---|---|
Revenue | CN¥3.12b |
Cost of Revenue | CN¥1.86b |
Gross Profit | CN¥1.26b |
Other Expenses | CN¥1.04b |
Earnings | CN¥224.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.31 |
Gross Margin | 40.42% |
Net Profit Margin | 7.20% |
Debt/Equity Ratio | 62.6% |
How did K0U perform over the long term?
See historical performance and comparison